These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors]. Miyata H Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):149-58. PubMed ID: 18800618 [TBL] [Abstract][Full Text] [Related]
3. Nicotine, brain nicotinic receptors, and neuropsychiatric disorders. Mihailescu S; Drucker-Colín R Arch Med Res; 2000; 31(2):131-44. PubMed ID: 10880717 [TBL] [Abstract][Full Text] [Related]
4. Nicotinic acetylcholine receptor system and neuropsychiatric disorders. Singh A; Potter A; Newhouse P IDrugs; 2004 Dec; 7(12):1096-103. PubMed ID: 15599803 [TBL] [Abstract][Full Text] [Related]
5. Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders. Pogocki D; Ruman T; Danilczuk M; Danilczuk M; Celuch M; Wałajtys-Rode E Eur J Pharmacol; 2007 Jun; 563(1-3):18-39. PubMed ID: 17376429 [TBL] [Abstract][Full Text] [Related]
6. Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor. Hernandez CM; Terry AV Neuroscience; 2005; 130(4):997-1012. PubMed ID: 15652996 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of histamine H3 receptor antagonists in dementias. Chazot PL Drug News Perspect; 2010 Mar; 23(2):99-103. PubMed ID: 20369074 [TBL] [Abstract][Full Text] [Related]
8. Nicotine as a therapeutic drug. Westman EC; Levin ED; Rose JE N C Med J; 1995 Jan; 56(1):48-51. PubMed ID: 7862206 [TBL] [Abstract][Full Text] [Related]
9. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Gotti C; Zoli M; Clementi F Trends Pharmacol Sci; 2006 Sep; 27(9):482-91. PubMed ID: 16876883 [TBL] [Abstract][Full Text] [Related]
11. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Court JA; Piggott MA; Lloyd S; Cookson N; Ballard CG; McKeith IG; Perry RH; Perry EK Neuroscience; 2000; 98(1):79-87. PubMed ID: 10858614 [TBL] [Abstract][Full Text] [Related]
12. Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research. Dursun SM; Kutcher S Med Hypotheses; 1999 Feb; 52(2):101-9. PubMed ID: 10340289 [TBL] [Abstract][Full Text] [Related]
13. [Nicotine acetylcholine receptors and neuropsychiatric disorders]. Vázquez-Palacios G; Bonilla-Jaime H Rev Neurol; 2004 Dec 16-31; 39(12):1146-60. PubMed ID: 15625635 [TBL] [Abstract][Full Text] [Related]
15. Development of nicotinic drug therapy for cognitive disorders. Levin ED; Rezvani AH Eur J Pharmacol; 2000 Mar; 393(1-3):141-6. PubMed ID: 10771007 [TBL] [Abstract][Full Text] [Related]
16. Chronic inhibition of alpha4beta2 nicotinic receptors in the ventral hippocampus of rats: impacts on memory and nicotine response. Arthur D; Levin ED Psychopharmacology (Berl); 2002 Mar; 160(2):140-5. PubMed ID: 11875631 [TBL] [Abstract][Full Text] [Related]
18. Effects of nicotinic stimulation on cognitive performance. Newhouse PA; Potter A; Singh A Curr Opin Pharmacol; 2004 Feb; 4(1):36-46. PubMed ID: 15018837 [TBL] [Abstract][Full Text] [Related]
19. Nicotinic systems in central nervous systems disease: degenerative disorders and beyond. Newhouse PA; Kelton M Pharm Acta Helv; 2000 Mar; 74(2-3):91-101. PubMed ID: 10812945 [TBL] [Abstract][Full Text] [Related]
20. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Newhouse PA; Potter A; Levin ED Drugs Aging; 1997 Sep; 11(3):206-28. PubMed ID: 9303280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]